Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Permanyer
2022-07-01
|
| Colección: | Gaceta Mexicana de Oncología |
| Materias: | |
| Acceso en línea: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|